[Inhibition of platelet functions by molsidomine in animals].
The effect of molsidomine on platelet function has been studied in various experimental models. Molsidomine prevented mortality induced by arachidonic acid as well as thrombocytopenia induced by collagenase, the combination of collagen plus adrenaline, or PAF-acether. Arterial bleeding time was prolonged. Carotid or coronary artery thrombosis and jugular venous thrombosis were inhibited. These effects were obtained in various animal species and were dose-dependent. They suggest the administration of molsidomine for the prevention of thrombotic disorders.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D006487:Hemostasis / Q000187:drug effects*; D008981:Molsidomine / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D013927:Thrombosis / Q000517:prevention & control*
D008981:Molsidomine
Inhibition des fonctions plaquettaires par la molsidomine chez l'animal.